2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide
C14H23IN4O3S — CID 120581676
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide
2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide (PubChem CID 120581676) has the molecular formula C14H23IN4O3S and a molecular weight of 454.33 g/mol. Its IUPAC name is 2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide.
Molecular Properties
| Compound Name | 2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide |
|---|---|
| PubChem CID | 120581676 |
| Molecular Formula | C14H23IN4O3S |
| Molecular Weight | 454.33 g/mol |
| Exact Mass | 454.05 |
| IUPAC Name | 2-[(2-methyl-4-sulfamoylphenyl)methyl]-1-(oxolan-2-ylmethyl)guanidine;hydroiodide |
| SMILES | Cc1cc(S(N)(=O)=O)ccc1C/N=C(\N)NCC1CCCO1.I |
| InChI | InChI=1S/C14H22N4O3S.HI/c1-10-7-13(22(16,19)20)5-4-11(10)8-17-14(15)18-9-12-3-2-6-21-12;/h4-5,7,12H,2-3,6,8-9H2,1H3,(H3,15,17,18)(H2,16,19,20);1H |
| InChIKey | KJDVQJMINYCSPR-UHFFFAOYSA-N |
| XLogP | 0.84 |
| TPSA | 119.80 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.33 |
| LogP ≤ 5 | 0.84 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120581676 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.